Clinical Outcomes After Valve Intervention in Rheumatic Mitral Valve Disease

This study identified older age and higher NYHA functional class as significant predictors of composite outcomes in patients with rheumatic MV disease requiring intervention. Left ventricular systolic dysfunction was independently associated with increased mortality following both percutaneous and surgical intervention. Long-term outcomes were comparable between patients undergoing PMV and MVR, reinforcing PMV as an effective alternative to surgery in appropriately selected patients.

Authors

Institutions

Publication Details

Journal
Global Heart
Published
2025-01-01
DOI
https://doi.org/10.5334/gh.1420
Citations
1
Primary Topic
Cardiac Valve Diseases and Treatments
Type
article
Field-Weighted Citation Impact
1.39

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Outcomes After Valve Intervention in Rheumatic Mitral Valve Disease

Bruno Ramos Nascimento, Robert A. Levine, Lucas Leal Fraga, Lucas Lodi‐Junqueira et al.
1 citations
Global Heart
Cardiac Valve Diseases and Treatments
1.39
article

Clinical Outcomes After Valve Intervention in Rheumatic Mitral Valve Disease

Bruno Ramos Nascimento, Robert A. Levine, Lucas Leal Fraga, Lucas Lodi‐Junqueira, Guilherme Rafael Sant’Anna Athayde, Marcia Fabrícia Almeida Teixeira, Cláudio Léo Gelape, Maria Carmo Pereira Nunes, Paulo Henrique Moreira Melo, Renato Bráulio, Marcus Vinícius Santos Andrade, Paulo Henrique Nogueira Costa, Marco Aurélio da Silva Neves
article en
1 citations

Abstract

This study identified older age and higher NYHA functional class as significant predictors of composite outcomes in patients with rheumatic MV disease requiring intervention. Left ventricular systolic dysfunction was independently associated with increased mortality following both percutaneous and surgical intervention. Long-term outcomes were comparable between patients undergoing PMV and MVR, reinforcing PMV as an effective alternative to surgery in appropriately selected patients.

Global HeartVol. 20(1)
Universidade Federal de Minas Gerais (BR), Harvard University (US), Massachusetts General Hospital (US), Hospital das Clínicas da Universidade Federal de Minas Gerais (BR)
Edwards Lifesciences, Fondation Leducq, Conselho Nacional de Desenvolvimento Científico e Tecnológico
Good health and well-being
Openalex Percentile: Top 21%
Cardiac Valve Diseases and Treatments
1.39
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Clinical Outcomes After Valve Intervention in Rheumatic Mitral Valve Disease — Bruno Ramos Nascimento, Robert A. Levine, et al. · Global Heart (2025) | TGRS Research Map | TGRS